[The complement system and its biological activities]. 1980

M G Colomb, and G J Arlaud

The complement system is a non specific humoral defence mechanism which can be triggered by various effectors : immune-complexes, extrinsic proteases, bacterial cell-wall polysaccharides, viral membranes. Different peptides or multimolecular complexes are formed by a cascade of proteolytic cleavages; they take an active part in the inflammatory response and may contribute to different pathological manifestations.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D002463 Cell Membrane Permeability A quality of cell membranes which permits the passage of solvents and solutes into and out of cells. Permeability, Cell Membrane
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003169 Complement Inactivator Proteins Serum proteins that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host. The complement system is tightly regulated by inactivators that accelerate the decay of intermediates and certain cell surface receptors. Complement Cytolysis Inhibiting Proteins,Complement Cytolysis Inhibitor Proteins,Complement Inactivating Proteins,Serum Complement Inactivators,Complement Inactivators, Serum,Inactivating Proteins, Complement,Inactivator Proteins, Complement,Inactivators, Serum Complement,Proteins, Complement Inactivating,Proteins, Complement Inactivator
D003170 Complement Pathway, Alternative Complement activation initiated by the interaction of microbial ANTIGENS with COMPLEMENT C3B. When COMPLEMENT FACTOR B binds to the membrane-bound C3b, COMPLEMENT FACTOR D cleaves it to form alternative C3 CONVERTASE (C3BBB) which, stabilized by COMPLEMENT FACTOR P, is able to cleave multiple COMPLEMENT C3 to form alternative C5 CONVERTASE (C3BBB3B) leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX. Alternative Complement Pathway,Properdin Pathway,Alternative Complement Activation Pathway,Complement Activation Pathway, Alternative
D003171 Complement Pathway, Classical Complement activation initiated by the binding of COMPLEMENT C1 to ANTIGEN-ANTIBODY COMPLEXES at the COMPLEMENT C1Q subunit. This leads to the sequential activation of COMPLEMENT C1R and COMPLEMENT C1S subunits. Activated C1s cleaves COMPLEMENT C4 and COMPLEMENT C2 forming the membrane-bound classical C3 CONVERTASE (C4B2A) and the subsequent C5 CONVERTASE (C4B2A3B) leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX. Classical Complement Pathway,Classical Complement Activation Pathway,Complement Activation Pathway, Classical
D000268 Adhesiveness A property of the surface of an object that makes it stick to another surface. Adhesivenesses
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).

Related Publications

M G Colomb, and G J Arlaud
June 1972, Annals of allergy,
M G Colomb, and G J Arlaud
July 1976, Nihon saikingaku zasshi. Japanese journal of bacteriology,
M G Colomb, and G J Arlaud
January 1978, Biochemical Society transactions,
M G Colomb, and G J Arlaud
January 1987, Reviews of physiology, biochemistry and pharmacology,
M G Colomb, and G J Arlaud
May 1981, Boletin de la Asociacion Medica de Puerto Rico,
M G Colomb, and G J Arlaud
December 1990, Biochemical Society transactions,
M G Colomb, and G J Arlaud
January 1977, Monographs in allergy,
M G Colomb, and G J Arlaud
January 1986, Progress in allergy,
M G Colomb, and G J Arlaud
October 1985, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
M G Colomb, and G J Arlaud
January 1971, Harvey lectures,
Copied contents to your clipboard!